Mineralocorticoid receptor antagonists reduce risk of cardiovascular events in patients with heart failure Post author: Post published:September 3, 2024 Post category:uncategorized MRAs significantly lower the risk of cardiovascular death and HF hospitalization in heart failure patients. You Might Also Like UVA researchers discover how Lactobacillus may help prevent depression and anxiety December 4, 2023 Are COVID-19 outcomes, including severe COVID-19 and persistent symptoms, associated with economic hardship among US families? December 13, 2023 New genomic insights could transform bipolar disorder treatment January 23, 2025
Are COVID-19 outcomes, including severe COVID-19 and persistent symptoms, associated with economic hardship among US families? December 13, 2023